www.fdanews.com/articles/126208-adeona-pharma-receives-positive-results-of-part-1-of-alzheimer-rsquo-s-study
Adeona Pharma Receives Positive Results of Part 1 of Alzheimer’s Study
April 14, 2010
Adeona Pharmaceuticals Inc. announced positive results of
Part 1 of its CopperProof-2 clinical study of Zinthionein ZC or zinc cysteine in Alzheimer’s
disease and mild cognitive impairment.
RTTNews
RTTNews